Janet Yellen, economics professor turned Federal Reserve chair, told graduates that success depends less on the “unfortunate myth” of ability and more on having the “grit” to persevere through setbacks.
Let’s dispense with the regular stuff today. It’s Friday, it’s finally May, and everyone’s in a good mood (unless you’re in Slovyansk). Yes, the drug companies are still rutting like caribou, the economy is looking a lot better, and the jobs report at 8:30 a.m. is forecast to be coming in fat. We’re expecting Berkshire Hathaway’s results today, too, but after this week of earnings and all this rain, you’re all beat. We know. We’ll pick up again on Monday.
Biogen Idec Inc. Chief Executive Officer George Scangos was skeptical when he learned company researchers were pursuing a new treatment for Lou Gehrig’s disease. No one knows the cause of the illness that killed the famous baseball player more than 70 years ago, and no medicine for it has been shown to slow its advance for long.